title: Interleukin-18 bioactivity and dose: data interpretation at a crossroads.
authors.affiliation: Department of Clinical Medicine, School of Medicine, Trinity College Dublin, Dublin 2, Ireland;
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Doyle
authors.affiliation: Ophthalmology, Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom;
authors.forename: Peter
authors.initials: P
authors.lastname: Adamson
authors.affiliation: Ophthalmology Discovery Performance Unit, GlaxoSmithKline, King of Prussia, Pennsylvania, United States; and.
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: López
authors.affiliation: Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
authors.forename: Peter
authors.initials: P
authors.lastname: Humphries
authors.affiliation: Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.
authors.forename: Matthew
authors.initials: M
authors.lastname: Campbell
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D020382:Interleukin-18 / Q000378:metabolism*; D008268:Macular Degeneration / Q000473:pathology*; D008297:Male; D055213:Retinal Pigment Epithelium / Q000473:pathology*
chemical_list: D020382:Interleukin-18